A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease
dc.contributor.author | Troeung, Lakkhina | |
dc.contributor.author | Egan, Sarah | |
dc.contributor.author | Gasson, Natalie | |
dc.date.accessioned | 2017-01-30T11:28:44Z | |
dc.date.available | 2017-01-30T11:28:44Z | |
dc.date.created | 2015-04-09T09:08:02Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Troeung, L. and Egan, S. and Gasson, N. 2014. A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease. BMC Psychiatry. 14 (19). | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/12104 | |
dc.identifier.doi | 10.1186/1471-244X-14-19 | |
dc.description.abstract |
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Therapy (CBT) treatment for depression and anxiety in Parkinson’s disease (PD). Methods: A waitlist-controlled trial design was used. Eighteen adults with PD and a comorbid DSM-IV-TR diagnosis of depression and/or anxiety were randomised to either Intervention (8-week group CBT treatment) or Waitlist (8-week clinical monitoring preceding treatment). The Depression, Anxiety, Stress Scale-21 (DASS-21) was the primary outcome. Assessments were completed at Time 1 (pretreatment), Time 2 (posttreatment/post-waitlist) and 1-month and 6-month follow-ups. Results: At Time 2, participants who received CBT reported greater reductions in depression (Mchange = -2.45) than Waitlist participants (Mchange = .29) and this effect was large, d = 1.12, p = .011. Large secondary effects on anxiety were also observed for CBT participants, d = .89, p = .025. All treatment gains were maintained and continued to improve during the follow-up period. At 6-month follow-up, significant and large effects were observed for both depression (d = 2.07) and anxiety (d = 2.26). Conclusions: Group CBT appears to be an efficacious treatment approach for depression and anxiety in PD however further controlled trials with larger numbers of participants are required. | |
dc.publisher | BioMed Central Ltd. | |
dc.subject | Parkinson’s disease | |
dc.subject | Depression | |
dc.subject | Anxiety | |
dc.subject | Psychotherapy | |
dc.subject | Randomised controlled trial | |
dc.subject | Cognitive behavioural therapy | |
dc.subject | Treatment | |
dc.title | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease | |
dc.type | Journal Article | |
dcterms.source.volume | 14 | |
dcterms.source.issn | 1471-244X | |
dcterms.source.title | BMC Psychiatry | |
curtin.note |
This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons Attribution License | |
curtin.department | School of Psychology and Speech Pathology | |
curtin.accessStatus | Open access |